Mapping of Cutaneous Leishmaniosis in Kerman City from 2002 to 2006 and its Environmental Risk Factors by Geographical Information System by A Mirzazadeh, B Hajarizadeh, B Mesgarpour, A Golozar, K Holakouie Naieni

Get full text

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia by B. Hajarizadeh, J. Grebely, G.V. Matthews, M. Martinello, G.J. Dore

Get full text

More than a virus: a qualitative study of the social implications of hepatitis B infection in China by J. Wallace, M. Pitts, C. Liu, V. Lin, B. Hajarizadeh, J. Richmond, S. Locarnini

Get full text

O12 Australia could meet the WHO HCV elimination targets if the current rollout of DAA treatment is continued by A.J. Kwon, G.J. Dore, J. Grebely, B. Hajarizadeh, R. Guy, E.B. Cunningham, C. Estes, H. Razavi, R.T. Gray

Get full text

P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study by E. Cunningham, J. Amin, N.A. Bretana, F. Luciani, L. Degenhardt, S. Larney, B. Hajarizadeh, G.J. Dore, A. Lloyd, J. Grebely

Get full text

O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study by M. Alavi, J. Amin, J. Grebely, M.G. Law, N.Z. Janjua, M. Krajden, B. Hajarizadeh, J. George, G.V. Matthews, S. Larney, L. Degenhardt, G.J. Dore

Get full text

O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study by B. Hajarizadeh, J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, N.K. Martin, J.G. McHutchison, D.M. Brainard, C. Treloar, A.R. Lloyd, G.J. Dore

Get full text

P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people by S. Bajis, F. Lamoury, T.L. Applegate, L. Maher, C. Treloar, Y. Mowat, M. Schulz, B. Hajarizadeh, A. Marshall, E. Cunningham, V. Cock, N. Ezard, C. Gorton, J. Hayllar, J. Smith, G.J. Dore, J. Grebely

Get full text

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by J. Grebely, O. Dalgard, B. Conway, E. Cunningham, P. Bruggmann, B. Hajarizadeh, J. Amin, P. Marks, S. Quiene, T.L. Applegate, T. Swan, J. Byrne, M. Lacalamita, A. Dunlop, J. Bruneau, M.E. Hellard, G.V. Matthews, J. Powis, D. Shaw, M.C. Thurnheer, M. Weltman, I. Kronborg, C. Cooper, J.J. Feld, C. Fraser, A. Litwin, J. Dillon, P. Read, E. Gane, G.J. Dore

Get full text